Scarica l'app Stockscreener
0.7301
8.87%
-0.0711
Pre-mercato:
.75
0.0199
+2.73%
Talphera Inc Borsa (TLPH) Ultime notizie
Talphera (TLPH) Reports Progress in Nafamostat Study and Financi - GuruFocus
Talphera: Q4 Earnings Snapshot - theheraldreview.com
Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals - Minichart
Talphera Q4 2025 & Investor Day Earnings Call Transcript - MarketBeat
Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN
Talphera Inc. Q4 & Fiscal 2025 Financial Results: Revenue & Net Loss ReportNews and Statistics - IndexBox
[10-K] TALPHERA, INC. Files Annual Report - Stock Titan
Talphera 2025 10-K: Revenue $0.028M, Net Loss $14.3M - TradingView
TLPH: Net loss increased to $14.3M in 2025; urgent capital needs and Nasdaq delisting risk persist - TradingView
Earnings call transcript: Talphera Inc. Q4 2025: Stock Declines Amid Study Delays - Investing.com India
Talphera, Inc. (NASDAQ: TLPH) 2026 Financial Results and Company Information Overview - Minichart
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Talphera Inc (TLPH) Reports Q4 Earnings - AlphaStreet
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Bitget
Talphera: Fourth Quarter Financial Results Overview - Bitget
Rate Hike: Can Talphera Inc grow without external fundingTake Profit & Comprehensive Market Scan Reports - baoquankhu1.vn
TLPH PE Ratio & Valuation, Is TLPH Overvalued - Intellectia AI
Talphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financing - MSN
Street Watch: Can Talphera Inc keep up with sector leaders2026 Trends & Capital Efficiency Focused Strategies - baoquankhu1.vn
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026 - ChartMill
Nantahala Capital-linked holders in Talphera (TLPH) acquire 4,266,211 pre-funded warrants - Stock Titan
Talphera, Inc. (formerly AcelRx Pharmaceuticals) Files Form 8-K – Company Details and SEC Filing Information - Minichart
Talphera (NASDAQ: TLPH) adds $4.1M in third private placement - Stock Titan
Talphera Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
Talphera, Inc. 8-K SEC Filing: Company Information, Address, NASDAQ Listing & Key Details (March 11, 2026) - Minichart
Talphera Received Notice of Noncompliance - TradingView
Talphera (NASDAQ: TLPH) faces Nasdaq minimum bid-price deficiency notice - Stock Titan
Sentiment Recap: Can Talphera Inc grow without external funding2025 Big Picture & Weekly High Return Stock Opportunities - baoquankhu1.vn
Aug Sentiment: Is Talphera Inc a top pick in the sectorJuly 2025 Selloffs & Daily Profit Maximizing Tips - baoquankhu1.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CalciMedica (CALC) and Talphera (TLPH) - The Globe and Mail
TLPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Talphera (TLPH) Achieves Key Enrollment Milestone in Clinical Tr - GuruFocus
Talphera reaches 50% enrollment in CRRT anticoagulant trial - Investing.com
Talphera announces 50% enrollment milestone in ongoing Nephro-Crrt registrational trial - marketscreener.com
Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial - TradingView
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial - marketscreener.com
Dow Update: What is Talphera Incs 5 year growth outlookMarket Growth Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Insider Buying: Talphera (NASDAQ:TLPH) Insider Acquires $28,350.00 in Stock - Defense World
Insider Buying: Talphera (NASDAQ:TLPH) CFO Buys $36,450.00 in Stock - Defense World
Talphera (NASDAQ:TLPH) Insider Purchases $28,350.00 in Stock - Defense World
Insider Buying: Talphera (NASDAQ:TLPH) CEO Purchases $85,344.84 in Stock - Defense World
Talphera CFO Asadorian buys $36k in TLPH stock By Investing.com - Investing.com South Africa
Aslam Shakil buys $28k in Talphera (TLPH) stock By Investing.com - Investing.com UK
Talphera (TLPH) CEO Angotti buys $85k in shares - Investing.com
Talphera (TLPH) CEO Angotti buys $85k in shares By Investing.com - Investing.com Australia
Talphera CFO Asadorian buys $36k in TLPH stock - Investing.com
Talphera’s Dasu Badri N buys $28,430 in shares - Investing.com Nigeria
Talphera’s Dasu Badri N buys $28,430 in shares By Investing.com - Investing.com Australia
Aslam Shakil buys $28k in Talphera (TLPH) stock - Investing.com
TALPHERA (TLPH) engineering chief buys 35K shares and receives 200K-option grant - Stock Titan
Rosalind Advisors, Inc. Expands Stake in Talphera Inc. - GuruFocus
Why Talphera Inc. (R5XA) stock stays undervaluedRate Cut & AI Optimized Trade Strategies - mfd.ru
Aug Chart Watch: Is APLT stock a good dividend stock2025 Macro Impact & Fast Exit Strategy with Risk Control - baoquankhu1.vn
1.75%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):